Vasopressin analogue and catecholamine

0 marketed 1 in Phase 3

This page covers all Vasopressin analogue and catecholamine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting V1A receptor and alpha-adrenergic receptor.

Targets

V1A receptor and alpha-adrenergic receptor

Phase 3 pipeline (1)

Patent intelligence